Filippo Milano

4.1k total citations · 1 hit paper
124 papers, 2.3k citations indexed

About

Filippo Milano is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Filippo Milano has authored 124 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hematology, 50 papers in Oncology and 24 papers in Immunology. Recurrent topics in Filippo Milano's work include Hematopoietic Stem Cell Transplantation (77 papers), Acute Myeloid Leukemia Research (29 papers) and Polyomavirus and related diseases (21 papers). Filippo Milano is often cited by papers focused on Hematopoietic Stem Cell Transplantation (77 papers), Acute Myeloid Leukemia Research (29 papers) and Polyomavirus and related diseases (21 papers). Filippo Milano collaborates with scholars based in United States, Italy and South Africa. Filippo Milano's co-authors include Colleen Delaney, Ted Gooley, Mohamed L. Sorror, Frederick R. Appelbaum, Roland B. Walter, Brent L. Wood, Brenda M. Sandmaier, Michael Boeckh, Ann Dahlberg and Hu Xie and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Filippo Milano

112 papers receiving 2.2k citations

Hit Papers

Cord-Blood Transplantation in Patients with Minimal Resid... 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cord-Blood Transplantation in Patients with Minimal Residual Disease
    2016 284 citations Filippo Milano, Ted Gooley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Filippo Milano United States 25 1.4k 752 486 424 371 124 2.3k
Jaime Sanz Spain 27 1.6k 1.2× 791 1.1× 372 0.8× 460 1.1× 356 1.0× 191 2.5k
Junya Kanda Japan 28 2.0k 1.4× 793 1.1× 426 0.9× 811 1.9× 412 1.1× 265 2.8k
Rudolf Trenschel Germany 27 1.2k 0.8× 603 0.8× 632 1.3× 733 1.7× 268 0.7× 64 2.1k
Tsiporah B. Shore United States 27 870 0.6× 919 1.2× 516 1.1× 264 0.6× 370 1.0× 152 2.3k
Hee‐Je Kim South Korea 26 2.0k 1.4× 736 1.0× 419 0.9× 717 1.7× 464 1.3× 271 3.0k
Carmen Di Grazia Italy 24 1.4k 1.0× 638 0.8× 386 0.8× 555 1.3× 253 0.7× 63 2.1k
Maura Faraci Italy 26 831 0.6× 695 0.9× 468 1.0× 363 0.9× 163 0.4× 121 2.2k
Isidro Jarque Spain 27 1.1k 0.8× 661 0.9× 739 1.5× 388 0.9× 444 1.2× 156 2.6k
Byung‐Sik Cho South Korea 24 1.5k 1.1× 560 0.7× 202 0.4× 580 1.4× 353 1.0× 189 2.3k
Shinichi Kako Japan 23 985 0.7× 727 1.0× 620 1.3× 303 0.7× 165 0.4× 178 1.9k

Countries citing papers authored by Filippo Milano

Since Specialization
Citations

This map shows the geographic impact of Filippo Milano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Milano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Milano more than expected).

Fields of papers citing papers by Filippo Milano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Milano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Milano. The network helps show where Filippo Milano may publish in the future.

Co-authorship network of co-authors of Filippo Milano

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Milano. A scholar is included among the top collaborators of Filippo Milano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Milano. Filippo Milano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tettero, Jesse M., Gege Gui, Filippo Milano, et al.. (2025). Significant Inter-Laboratory Variability in Measurable Residual Disease Multiparameter Flow Cytometry Testing Prior to Allogeneic Transplantation Impedes Outcome Prediction: A CIBMTR Analysis. Transplantation and Cellular Therapy. 31(2). S117–S118. 1 indexed citations
2.
Mehta, Rohtesh S., Rodney Sparapani, Christopher G. Kanakry, et al.. (2025). Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide vs Conventional Prophylaxis. JAMA Oncology. 12(1). 28–28. 2 indexed citations
3.
Mehta, Rohtesh S., Hannah Choe, Jennifer N. Saultz, et al.. (2025). Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Hematology. 100(6). 987–997.
4.
Mehta, Rohtesh S., Stephanie J. Lee, Ted Gooley, et al.. (2025). Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignancies. Blood Advances. 9(11). 2691–2694.
5.
Mehta, Rohtesh S., Yosra Aljawai, Taha Al‐Juhaishi, et al.. (2025). Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis. Transplantation and Cellular Therapy. 31(9). 672.e1–672.e9. 1 indexed citations
6.
7.
Orvain, Corentin, Megan Othus, Eduardo Rodríguez‐Arbolí, et al.. (2024). Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American Journal of Hematology. 99(5). 862–870. 4 indexed citations
8.
Milano, Filippo, et al.. (2024). Dilanubicel, a Non-HLA-Matched Pooled Universal Product, Transforming Single Cord Blood Transplantation Success Rates. Blood. 144(Supplement 1). 377–377. 1 indexed citations
9.
Daver, Naval, Abhishek Maiti, David A. Sallman, et al.. (2024). A first-in-human phase 1, multicenter, open-label study of CB-012, a next-generation CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy for adults with relapsed/refractory acute myeloid leukemia (AMpLify).. Journal of Clinical Oncology. 42(16_suppl). TPS6586–TPS6586. 5 indexed citations
10.
Huang, Jennifer J., Emily C. Liang, Andrew J. Portuguese, et al.. (2024). Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.. Journal of Clinical Oncology. 42(16_suppl). 7034–7034. 2 indexed citations
11.
Huang, Jennifer J., Ryan Basom, Andrea Kalus, et al.. (2024). Autoimmune Outcomes in Patients with Concurrent Autoimmune Disease Receiving CD19 CAR T-Cell Therapy for Lymphoma. Blood. 144(Supplement 1). 7132–7132. 1 indexed citations
12.
Othus, Megan, Eduardo Rodríguez‐Arbolí, Corentin Orvain, et al.. (2024). Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia. Bone Marrow Transplantation. 59(12). 1667–1675.
13.
Connelly‐Smith, Laura, Ted Gooley, Marco Mielcarek, et al.. (2023). Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. Transplantation and Cellular Therapy. 29(11). 700.e1–700.e8. 4 indexed citations
14.
Rashidi, Armin, Fei Gao, David N. Fredricks, et al.. (2023). Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation. JAMA Network Open. 6(6). e2317188–e2317188. 21 indexed citations
15.
Voutsinas, Jenna, Andrew J. Portuguese, Jennifer J. Huang, et al.. (2023). Factors Associated with Prolonged CRS and Neurotoxicity after Treatment with Axicabtagene Ciloleucel. Blood. 142(Supplement 1). 2126–2126. 1 indexed citations
16.
O’Donnell, Paul V., Claudio G. Brunstein, Ephraim J. Fuchs, et al.. (2021). Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. Transplantation and Cellular Therapy. 28(2). 109.e1–109.e8. 10 indexed citations
17.
Politikos, Ioannis, Eric Davis, John E. Wagner, et al.. (2020). Guidelines for Cord Blood Unit Selection. Biology of Blood and Marrow Transplantation. 26(12). 2190–2196. 38 indexed citations
18.
Xue, Elisabetta, Tatiana Lawrence, Terry Gernsheimer, & Filippo Milano. (2019). Retrospective Evaluation of the Use of Romiplostim after Hematopoietic Stem Cell Transplantation0. Blood. 134(Supplement_1). 5660–5660. 1 indexed citations
19.
Dahlberg, Ann & Filippo Milano. (2016). Cord blood transplantation: rewind to fast forward. Bone Marrow Transplantation. 52(6). 799–802. 13 indexed citations
20.
Milano, Filippo, Margaret A. Au, Michael Boeckh, H. Joachim Deeg, & Jason W. Chien. (2010). Evaluating the Impact of Antithymocyte Globulin on Lung Function at 1 Year after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(5). 703–709. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaime Sanz Breakdown of academic impact, for papers by Junya Kanda Breakdown of academic impact, for papers by Rudolf Trenschel Breakdown of academic impact, for papers by Tsiporah B. Shore Breakdown of academic impact, for papers by Hee‐Je Kim Breakdown of academic impact, for papers by Carmen Di Grazia Breakdown of academic impact, for papers by Maura Faraci Breakdown of academic impact, for papers by Isidro Jarque Breakdown of academic impact, for papers by Byung‐Sik Cho Breakdown of academic impact, for papers by Shinichi Kako
Rankless by CCL
2026